UCB SA (UCB.BR)

EUR 169.2

(5.0%)

Net Debt Summary of UCB SA

UCB SA's latest annual net debt in 2023 was 2.17 Billion EUR , up 8.8% from previous year.
UCB SA's latest quarterly net debt in 2024 Q2 was 2.41 Billion EUR , down 0.0% from previous quarter.
UCB SA reported annual net debt of 2 Billion EUR in 2022, up 132.67% from previous year.
UCB SA reported annual net debt of 860 Million EUR in 2021, down -58.75% from previous year.
UCB SA reported quarterly net debt of 2.17 Billion EUR for 2023 FY, up 8.8% from previous quarter.
UCB SA reported quarterly net debt of 2.43 Billion EUR for 2023 Q2, down 0.0% from previous quarter.

Annual Net Debt Chart of UCB SA (2023 - 2002)

Historical Annual Net Debt of UCB SA (2023 - 2002)

Year	Net Debt	Net Debt Growth
2023	2.17 Billion EUR	8.8%
2022	2 Billion EUR	132.67%
2021	860 Million EUR	-58.75%
2020	2.08 Billion EUR	119.01%
2019	952 Million EUR	301.69%
2018	237 Million EUR	-54.77%
2017	524 Million EUR	-37.62%
2016	840 Million EUR	-31.03%
2015	1.21 Billion EUR	-24.49%
2014	1.61 Billion EUR	-19.35%
2013	2 Billion EUR	13.06%
2012	1.76 Billion EUR	14.13%
2011	1.55 Billion EUR	-1.4%
2010	1.57 Billion EUR	-10.53%
2009	1.75 Billion EUR	-28.29%
2008	2.45 Billion EUR	26.22%
2007	1.94 Billion EUR	-9.3%
2006	2.14 Billion EUR	239.14%
2005	631 Million EUR	-69.51%
2004	2.06 Billion EUR	4905.76%
2003	-43.06 Million EUR	91.07%
2002	-482.37 Million EUR	0.0%

Year	Net Debt	Net Debt Growth
2024 Q2	2.41 Billion EUR	0.0%
2023 FY	2.17 Billion EUR	8.8%
2023 Q2	2.43 Billion EUR	0.0%
2023 Q4	2.17 Billion EUR	0.0%
2022 FY	2 Billion EUR	132.67%
2022 Q2	2.5 Billion EUR	0.0%
2022 Q4	2 Billion EUR	0.0%
2021 Q2	1.51 Billion EUR	0.0%
2021 Q4	860 Million EUR	0.0%
2021 FY	860 Million EUR	-58.75%
2020 Q4	2.08 Billion EUR	0.0%
2020 Q2	1.91 Billion EUR	0.0%
2020 FY	2.08 Billion EUR	119.01%
2019 Q4	952 Million EUR	0.0%
2019 FY	952 Million EUR	301.69%
2019 Q2	387 Million EUR	0.0%
2018 Q4	237 Million EUR	0.0%
2018 FY	237 Million EUR	-54.77%
2018 Q2	773 Million EUR	0.0%
2017 FY	524 Million EUR	-37.62%
2017 Q2	988 Million EUR	0.0%
2017 Q4	524 Million EUR	0.0%
2016 Q4	840 Million EUR	0.0%
2016 FY	840 Million EUR	-31.03%
2016 Q2	1.34 Billion EUR	0.0%
2015 Q4	923 Million EUR	0.0%
2015 Q2	1.81 Billion EUR	0.0%
2015 FY	1.21 Billion EUR	-24.49%
2014 Q2	1.73 Billion EUR	0.0%
2014 FY	1.61 Billion EUR	-19.35%
2014 Q4	1.61 Billion EUR	0.0%
2013 Q4	2.01 Billion EUR	0.0%
2013 FY	2 Billion EUR	13.06%
2013 Q2	2.09 Billion EUR	0.0%
2012 Q2	1.76 Billion EUR	0.0%
2012 FY	1.76 Billion EUR	14.13%
2012 Q4	1.76 Billion EUR	0.0%
2011 Q4	1.55 Billion EUR	0.0%
2011 Q2	1.42 Billion EUR	0.0%
2011 FY	1.55 Billion EUR	-1.4%
2010 FY	1.57 Billion EUR	-10.53%
2010 Q4	1.57 Billion EUR	0.0%
2010 Q2	1.87 Billion EUR	0.0%
2009 Q4	1.75 Billion EUR	0.0%
2009 FY	1.75 Billion EUR	-28.29%
2008 FY	2.45 Billion EUR	26.22%
2007 FY	1.94 Billion EUR	-9.3%
2006 FY	2.14 Billion EUR	239.14%
2005 FY	631 Million EUR	-69.51%
2004 FY	2.06 Billion EUR	4905.76%
2003 FY	-43.06 Million EUR	91.07%
2002 FY	-482.37 Million EUR	0.0%

Peer Net Debt Comparison of UCB SA

Name	Net Debt	Net Debt Difference
Nicox S.A.	13.89 Million EUR	-15568.634%
European Medical Solutions	13.93 Million EUR	-15527.019%
FERMENTALG	4.19 Million EUR	-51819.866%
argenx SE	-1.83 Billion EUR	218.532%
BioSenic S.A.	28.04 Million EUR	-7662.801%
Celyad Oncology SA	-6.1 Million EUR	35776.827%
Hyloris Pharmaceuticals SA	-25.11 Million EUR	8769.162%
Onward Medical N.V.	-12.89 Million EUR	16983.822%
Oxurion NV	10.71 Million EUR	-20226.797%
PHAXIAM Therapeutics S.A.	-275 Thousand EUR	791736.364%
Financière de Tubize SA	78.62 Million EUR	-2668.834%